| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase II trial and quality-of-life analysis of a 5-day regimen of oral 5-fluorouracil bracketed by a 7-day regimen of oral eniluracil in untreated patients with unresectable or metastatic colorectal carcinoma
|
Hobday, TimothyJ.
|
|
2002
|
24 |
S2 |
p. 47-48
2 p.
|
artikel
|
| 2 |
A randomized assessment of three quality-of-life questionnaires for patients with prostate cancer undergoing different radiation treatments
|
Senter, KimberlyK.
|
|
2002
|
24 |
S2 |
p. 31-33
3 p.
|
artikel
|
| 3 |
A rasch analysis of the functional scales of the European Organization for Research and Treatment of Cancer QLQ-C30 and the implications for clinical significance
|
Smith, AdamB.
|
|
2002
|
24 |
S2 |
p. 34-35
2 p.
|
artikel
|
| 4 |
Assessing meaningful change over time in quality of life: A user's guide for clinicians
|
Sprangers, MirjamA.G.
|
|
2002
|
24 |
S2 |
p. 8-
1 p.
|
artikel
|
| 5 |
Assessing the clinical significance of quality-of-life measures in oncology research: State of the science
|
Sloan, Jeff A
|
|
2002
|
24 |
S2 |
p. 1-4
4 p.
|
artikel
|
| 6 |
Assessing the clinical significance of single items relative to summated scores
|
Sloan, JeffA.
|
|
2002
|
24 |
S2 |
p. 6-7
2 p.
|
artikel
|
| 7 |
Assessment of palliation in patients with lung cancer: Comparisons between patient symptom diary scores and “minimum clinical change” in quality-of-life scores
|
Brundage, MichaelD.
|
|
2002
|
24 |
S2 |
p. 23-24
2 p.
|
artikel
|
| 8 |
Clarifying the significance of treatment effects on quality-of-life dimensions using structural equation modeling: Example from peripheral arterial obstructive diseases
|
Marquis, Patrick
|
|
2002
|
24 |
S2 |
p. 37-
1 p.
|
artikel
|
| 9 |
Clinical benefit in patients with cancer of the pancreas: How does it compare with clinically significant changes in quality-of-life scores?
|
Bezjak, Andrea
|
|
2002
|
24 |
S2 |
p. 12-14
3 p.
|
artikel
|
| 10 |
Clinical significance of changes in quality-of-life scores during neoadjuvant treatment of esophageal cancer
|
Blazeby, JaneM.
|
|
2002
|
24 |
S2 |
p. 38-39
2 p.
|
artikel
|
| 11 |
Clinical significance of quality of life: The patient advocate perspective
|
Chauhan, Cynthia
|
|
2002
|
24 |
S2 |
p. 30-
1 p.
|
artikel
|
| 12 |
Confirmatory factor analysis and clinical significance of the illness intrusiveness ratings scale in men and women with common cancer diagnoses
|
Devins, GeraldM.
|
|
2002
|
24 |
S2 |
p. 25-26
2 p.
|
artikel
|
| 13 |
Correlations between target scores and anchor ratings on a health transition questionnaire
|
Osoba, David
|
|
2002
|
24 |
S2 |
p. 26-27
2 p.
|
artikel
|
| 14 |
Group versus individual approaches to understanding the clinical significance of differences or changes in quality of life
|
Cella, David
|
|
2002
|
24 |
S2 |
p. 6-
1 p.
|
artikel
|
| 15 |
Improving the quality of life for patients with cancer through the cancer supportive care program and web site
|
Rosenbaum, ErnestH.
|
|
2002
|
24 |
S2 |
p. 11-12
2 p.
|
artikel
|
| 16 |
Interpretation of change and longitudinal validity of the quality of life for respiratory illness questionnaire in inpatient pulmonary rehabilitation
|
van Stel, HenkF.
|
|
2002
|
24 |
S2 |
p. 17-18
2 p.
|
artikel
|
| 17 |
Interpretation of quality-of-life data from a clinician's point of view: Getting to the clinical part of clinically meaningful change
|
Dennison, CherylR.
|
|
2002
|
24 |
S2 |
p. 40-41
2 p.
|
artikel
|
| 18 |
Long-term quality of life associated with a chemotherapy-based regimen for newly diagnosed central nervous system germ cell tumors: The first international cooperative trial
|
Sands, StephenA.
|
|
2002
|
24 |
S2 |
p. 28-
1 p.
|
artikel
|
| 19 |
Meaningful change in cancer-specific quality-of-life scores: Differences between improvement and worsening
|
Dineen, Kelly
|
|
2002
|
24 |
S2 |
p. 41-42
2 p.
|
artikel
|
| 20 |
Measurement of fatigue: Determining minimally important clinical differences
|
Schwartz, AnnaL.
|
|
2002
|
24 |
S2 |
p. 14-16
3 p.
|
artikel
|
| 21 |
Measuring the quality of life of patients with breast cancer treated with breast-conserving techniques
|
Hardy, MariaM.
|
|
2002
|
24 |
S2 |
p. 30-31
2 p.
|
artikel
|
| 22 |
Methods for explaining the clinical significance of health status measures
|
Guyatt, GordonH.
|
|
2002
|
24 |
S2 |
p. 5-
1 p.
|
artikel
|
| 23 |
Minimal important difference: Can we predict its magnitude?
|
Ringash, JolieG.
|
|
2002
|
24 |
S2 |
p. 22-23
2 p.
|
artikel
|
| 24 |
Patient, clinician, and population perspectives on determining the clinical significance of quality-of-life scores
|
Frost, MarleneH.
|
|
2002
|
24 |
S2 |
p. 7-8
2 p.
|
artikel
|
| 25 |
Quality-of-life and behavioral follow-up study of pediatric craniopharyngioma survivors
|
Sands, StephenA.
|
|
2002
|
24 |
S2 |
p. 29-
1 p.
|
artikel
|
| 26 |
Quality-of-life changes during the first cycle of myelosuppressive chemotherapy
|
Fortner, BarryV.
|
|
2002
|
24 |
S2 |
p. 46-47
2 p.
|
artikel
|
| 27 |
Quality-of-life measures as leading indicators of adverse clinical events after bone marrow and stem cell transplantation
|
Bush, NigelE.
|
|
2002
|
24 |
S2 |
p. 9-11
3 p.
|
artikel
|
| 28 |
Quality of life of cancer patients as reported in a tumor registry follow-up
|
Harris, MarcellineR.
|
|
2002
|
24 |
S2 |
p. 43-44
2 p.
|
artikel
|
| 29 |
Response shift in individualized quality of life in patients with advanced prostate cancer
|
Rees, JonathanE.
|
|
2002
|
24 |
S2 |
p. 33-34
2 p.
|
artikel
|
| 30 |
The cancer outcomes measurement working group: Evaluating the state of the science and developing recommendations for improving outcomes assessment in cancer
|
Snyder, Claire
|
|
2002
|
24 |
S2 |
p. 21-
1 p.
|
artikel
|
| 31 |
The clinical significance of QOL results: Practical considerations for specific audiences
|
Symonds, Tara
|
|
2002
|
24 |
S2 |
p. 8-9
2 p.
|
artikel
|
| 32 |
Use of event charts for summarizing clinically significant changes in oncology quality-of-life data
|
Atherton, PamelaJ.
|
|
2002
|
24 |
S2 |
p. 48-49
2 p.
|
artikel
|
| 33 |
Use of individual quality-of-life data in oncology consultations: Approach to interpretation of individual results and physicians' feedback on clinical usefulness
|
Velikova, GalinaI.
|
|
2002
|
24 |
S2 |
p. 35-36
2 p.
|
artikel
|
| 34 |
Using patient- and clinician-rated anchors to evaluate change on the functional assessment of cancer therapy—biologic response modifiers
|
Hahn, ElizabethA.
|
|
2002
|
24 |
S2 |
p. 19-20
2 p.
|
artikel
|
| 35 |
What does it all mean? Using health-related quality-of-life data to interpret treatment outcomes
|
Leidy, NancyK.
|
|
2002
|
24 |
S2 |
p. 39-40
2 p.
|
artikel
|
| 36 |
What is measured by the schedule for the evaluation of individual quality of life-direct weighting?
|
Vielhaber, Annette
|
|
2002
|
24 |
S2 |
p. 44-45
2 p.
|
artikel
|
| 37 |
What is the relationship between clinical and health-related quality-of-life measures?
|
Hagan, Michael
|
|
2002
|
24 |
S2 |
p. 16-17
2 p.
|
artikel
|
Tijdschrift beschrijving